Home/Filings/4/0001610717-25-000370
4//SEC Filing

Lester Rachael 4

Accession 0001610717-25-000370

CIK 0001501989other

Filed

Oct 28, 8:00 PM ET

Accepted

Oct 29, 4:50 PM ET

Size

5.5 KB

Accession

0001610717-25-000370

Insider Transaction Report

Form 4
Period: 2025-10-20
Lester Rachael
Chief Business Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-10-20+650,000650,000 total
    Exercise: $3.74Exp: 2035-10-19Common Stock (650,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the option vest on the one year anniversary measured from October 20, 2025 (the "Vesting Commencement Date"), and 1/48th of the shares will vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date.

Documents

1 file

Issuer

CytomX Therapeutics, Inc.

CIK 0001501989

Entity typeother

Related Parties

1
  • filerCIK 0002094324

Filing Metadata

Form type
4
Filed
Oct 28, 8:00 PM ET
Accepted
Oct 29, 4:50 PM ET
Size
5.5 KB